Medinotec Inc (MDNC) Return on Equity ROE from the second quarter 2026 to second quarter 2026 and annually, average high and low, overall ranking from Aug 31 2026 to Aug 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medinotec Inc   (MDNC)

Medinotec Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Medinotec Inc in the second quarter 2026?
Medinotec Inc achieved a return on average equity (ROE) of 10.38 % in its second quarter 2026, which is below Medinotec Inc 's average return on equity, which stands at 22.55%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 35 other companies had a higher return on equity. While the total ranking for ROE unchanged, relative to the first quarter 2026 at no. 843.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Aug 31 2026)
II. Quarter		 (May 31 2026)
I. Quarter		 (Feb 28 2026)
IV. Quarter		 (Nov 30 2025)
III. Quarter		 (Aug 31 2025)
II. Quarter
Y / Y Equity Change 22.67 % 33.96 % 33.73 % 94.64 % -
Y / Y Net Income Change -88.21 % 95.12 % - 30 % 21.71 %
Net Income (TTM) in Millions 1 1 1 2 2
Return On Equity (TTM) 10.38 % 16.49 % 15.57 % 49.34 % 55.15 %
MDNC's Total Ranking # 843 # 843 # 839 # 5 # 39
Equity (TTM) in Millions 6 6 6 6 5
Seq. Equity Change 1.4 % 2.47 % 3.84 % 13.7 % 10.72 %
Seq. Net Income Change -81.59 % - - 16.4 % 204.58 %

Back to MDNC Management Effectiveness >> MDNC's 5 Years Annual ROE >> Compare MDNC ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 36
Sector # 130
Overall # 843

Return On Equity Statistics
High Average Low
77 %
22.55 %
-23.5 %
(Feb 28 2025)   (Feb 29 2024)





MDNC Annual Return On Equity (Feb 28 2026)
2026		 (Feb 28 2025)
2025		 (Feb 29 2024)
2024		 (Feb 28 2023)
2023
Total Equity in Millions 6 4 2 0 0
Y / Y Equity Change 33.73 % 97.07 % - - -
Net Income in Millions 1 2 0 0 0
Y / Y Net Income Change -63.21 % - - - -
Return On Equity 13.91 % 50.56 % -18.67 % - -

Back to MDNC Management Effectiveness >> MDNC's 5 Years Annual ROE >> Compare MDNC ROE to its Competitors




Annual Roe Comment
In 2026 ROE decreased compared to the previous year to 13.91 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MDNC's' Return on Equity at Yahoo Finance
MDNC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MDNC's Competitors
Subscribers only: Roe for Medinotec Inc 's Suppliers
Subscribers only: Return On Equity for MDNC's Customers




Companies with similar Return On Equity at Aug 31 2026, within Healthcare Sector ROE
Acadia Pharmaceuticals Inc   28.03 %
Pro dex Inc   26.91 %
Sotera Health Company  26.41 %
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %
Corcept Therapeutics Inc  22.88 %
Msa Safety Inc  21.79 %
Lantheus Holdings Inc   21.72 %
Iqvia Holdings Inc   21.40 %
Denali Therapeutics Inc   21.40 %
West Pharmaceutical Services Inc   21.08 %
Brightspring Health Services Inc   20.31 %
Healthcare Services Group Inc   20.22 %
Vertex Pharmaceuticals Inc  20.08 %
Ge Healthcare Technologies Inc   20.04 %
Neurocrine Biosciences Inc   19.74 %
Ani Pharmaceuticals Inc  19.70 %
Johnson and Johnson  19.55 %
Beone Medicines Ltd   18.21 %
Pediatrix Medical Group Inc   17.28 %
Kiniksa Pharmaceuticals International Plc  17.27 %
Krystal Biotech Inc   17.02 %
Intuitive Surgical Inc   16.99 %
Ensign Group Inc  16.62 %
Lemaitre Vascular Inc   15.81 %
Stryker Corp  15.61 %

Date modified: 2026-10-09T04:24:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.